Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preeclampsia Intervention 4
NCT06033131Phase 3Recruiting
- Start
- Jan 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in preeclampsia. Started Jan 2024; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT06033131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06033131.